Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Bassem I Yammout"'
Autor:
Bassem I Yammout, Gavin Giovannoni, Celia Oreja-Guevara, Diego Centonze, Hashem Salloukh, Le H. Hua, Peter Rieckmann, Daniel Selchen, Patrick Vermersch, Per Soelberg Sørensen, Heinz Wiendl
BackgroundGaps in current evidence and guidance leave clinicians with unanswered questions on the use of cladribine tablets for the treatment of multiple sclerosis (MS) in the era of the COVID-19 pandemic, in particular relating to COVID-19 vaccinati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4b0ba15f2c893936e480803f1b57acc4
https://doi.org/10.1101/2021.06.22.21259308
https://doi.org/10.1101/2021.06.22.21259308
Autor:
Rana Karabudak, Abdulkader Daif, I. Alsharoqi, Karim Taha, Raed Alroughani, Maurice Dahdaleh, Dirk Deleu, Saeed Bohlega, Mohammed A. Sahraian, Magd Zakaria, Mohammed Aljumah, Abdulrahman Al-Tahan, Jihad Inshasi, Bassem I Yammout
Publikováno v:
The International journal of neuroscience. 127(10)
Disease-modifying therapies (DMTs) delay or may prevent the progression of patients with high-risk clinically isolated syndrome (CIS) to clinically definite multiple sclerosis (MS), and from relapsing-remitting MS to secondary progressive MS. Current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fedf1efb467db1b9767b13b178dff4
https://pubmed.ncbi.nlm.nih.gov/28029270
https://pubmed.ncbi.nlm.nih.gov/28029270
